Skip to content

Clinical trials

Phase 2 Autism Spectrum Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 2 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20123
20133
20141
20161
20191
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status2
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Holland Bloorview Kids Rehabilitation Hospital9
Evdokia Anagnostou2
Forest Laboratories2
MapLight Therapeutics2
Hoffmann-La Roche1
Jazz Pharmaceuticals1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder18
Autistic Disorder8
Anxiety Disorders2
Asperger Syndrome2
22q11 Deletion Syndrome1
Attention Deficit Disorder with Hyperactivity1
DiGeorge Syndrome1
Fragile X Syndrome1
Neurodevelopmental Disorders1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.